Trademark Overview
On Friday, March 13, 2026, a trademark application was filed for BFORSEV with the United States Patent and Trademark Office. The USPTO has given the BFORSEV trademark a serial number of 99700178. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, March 13, 2026. This trademark is owned by Glaxo Group Limited. The BFORSEV trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives